Company / Interest Expense
Akebia Therapeutics, Inc. Interest Expense History
FY2014-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-$704.0K
FY2015
5-year range
-
FY2014-FY2015
Trend
+57.2%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$704,000 in FY2015.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, interest expense increased 57.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2015 | -$704.0K | +57.2% |
| FY2014 | -$1.6M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026